
Ferm Labs, a Zug-based ingredient startup, has raised €3 million in new funding. The company develops high-yield bioprocessing technology to produce clean-label ingredients.
The funding round was led by CDP Venture Capital through its Green Transition Fund and NextGenerationEU. Other investors included Fund F, Redstone in partnership with Euregio+ and Alpine VC and food industry company Loacker.
“Ferm Labs has built an extraordinary DeepTech platform that redefines efficiency, sustainability, and flavour performance. We are thrilled to lead this round and support Stephanie, Mattia and the team as they scale manufacturing and drive European expansion,” said Enrico Filì, Head of Green Transition Fund at CDP Venture Capital.
Founded in 2025 by serial entrepreneurs Stephanie Lüpold, CEO, and Mattia Baroni, CTO, Ferm Labs is building a new type of B2B flavour technology for the food industry.
The company develops clean-label ingredients that aim to deliver the same taste and sensory experience as traditional flavours while being more natural and cost-effective.
Ferm Labs says food manufacturers have traditionally had to choose between low-cost synthetic additives and natural ingredients that can be slower and more expensive to produce.
The company aims to solve this problem by developing natural, high-performance ingredients that can offer both better quality and cost efficiency.
“The era of flavour trade-offs is officially over. Kokumesan proves what our platform can do in cheese flavouring, but it is just our launchpad. We are building a category-defining B2B ingredient engine – powering the next era of natural food by uniting deep-tech bioprocessing with uncompromising taste at global scale,” said Lüpold.
“We essentially broke the math on industrial flavour kinetics. By accelerating fermentation speed and yield, we eliminated the cost penalty of natural ingredients while delivering a richer, cleaner profile at an unbeatable cost-in-use,” said Baroni.
Ferm Labs is headquartered in Zug, with its production operations based in Bolzano. The company will use the new funding to increase its bioprocessing capacity in South Tyrol.
The funding will also help Ferm Labs expand its European B2B sales team and grow its R&D team as it develops new product categories.